Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how the Bloomberg Global Innovative Biopharma Index (BGIBT) can help track value creation across the biopharma ecosystem.
The financial industry faces evolving regulations and government expectations in the push to advance the green transition. Green finance policy updates below highlight regulatory and policy insights available to Bloomberg Terminal subscribers.
Recent periods of financial stress and the proliferation of risks across the financial system are fueling the development of regulatory initiatives to strengthen requirements and promote international best practice.
Regulatory authorities continue to advance initiatives to improve financial market structures. The following market structure policy developments represent a sample of wider regulatory and policy coverage available to Bloomberg Terminal customers.
As technology continues to reshape financial services, regulators and policy setters are embarking on a range of digital finance initiatives to manage risks and set appropriate standards.
